Market Overview:
The global cervical dystonia treatment market is expected to register a CAGR of XX% during the forecast period 2018-2030. The market growth can be attributed to the increasing prevalence of cervical dystonia, rising awareness about available treatments, and growing demand for better treatment options. Based on type, the global cervical dystonia treatment market is segmented into botulinum toxin therapy, anticholinergic agents, dopaminergic agents, and others. Botulinum toxin therapy is expected to dominate the market during the forecast period owing to its high efficacy and safety profile. Based on application, the global cervical dystonia treatment market is segmented into hospital pharmacy, retail pharmacies, online pharmacies and others. Hospital pharmacy dominates the application segment due to increased use of drugs for treating chronic diseases in hospitals.
Product Definition:
Cervical dystonia is a neurological disorder that causes involuntary muscle contractions in the neck. This can lead to abnormal postures of the head and neck, and pain. Treatment may include medications, injections, or surgery. The goal of treatment is to reduce symptoms and improve quality of life.
Botulinum:
Botulinum toxin is a neurotoxin and it's produced by an anaerobic bacterium, Clostridium botulinum. It has three types, A, B and C which are different forms of the same protein. Type A is the most potent form of botulinum toxin with about 100 times more than type B and 200 times more than type C.
Anticholinergic Agents:
Anticholinergic agents are used to treat symptoms of cervical dystonia such as muscle spasms, cramps, and stiff muscles. This medication works by blocking the action of a chemical messenger known as acetylcholine which is responsible for contraction of muscles. Some anticholinergic drugs such as scopolamine are also used in the treatment of motion sickness caused due to travel in cars, boats or aircraft.
Application Insights:
Based on application, the global market is segmented into hospital pharmacy, retail pharmacies, online pharmacies and others. The hospital pharmacy held the largest share in 2017 owing to its usage in treating acute cases where dystonia has just been diagnosed. In addition, it is also used for chronic conditions where other treatment methods have failed or patients have remained unresponsive.
The online pharmacy was estimated to be the fastest-growing segment from 2018 to 2030 due largely to an increase in demand for drugs with minimal or no side effects among young people who suffer from this condition. Moreover, a large number of pharmaceutical companies are developing drugs specifically designed for cervical dystonia which may further boost growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and high patient awareness levels are some of the factors contributing to its growth. Moreover, increasing cases of neck pain and other associated disorders are expected to drive demand for treatment options in this region. According to a study published by National Spinal Cord Injury Statistical Center (NSCISC), Inc., approximately 285,000 people were reported with cervical injuries in the U.S.
Asia Pacific is anticipated to be one of fastest-growing regions during the forecast period owing to rising healthcare expenditure and improving economic conditions especially in India & China that have a high prevalence rate for this condition.
Growth Factors:
- Increasing incidence of cervical dystonia
- Growing awareness about the disease among people
- Rising demand for better treatment options for cervical dystonia patients
- Availability of new and innovative therapies for the treatment of cervical dystonia
- increasing research and development activities in the field of cervical dystonia
Scope Of The Report
Report Attributes
Report Details
Report Title
Cervical Dystonia Treatment Market Research Report
By Type
Botulinum, Anticholinergic Agents, Dopaminergic Agents, Others
By Application
Hospital Pharmacy, Retail Pharmacies, Online Pharmacy, Others
By Companies
Merz Pharma, US WorldMeds, Allergan, Ipsen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Cervical Dystonia Treatment Market Report Segments:
The global Cervical Dystonia Treatment market is segmented on the basis of:
Types
Botulinum, Anticholinergic Agents, Dopaminergic Agents, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacies, Online Pharmacy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merz Pharma
- US WorldMeds
- Allergan
- Ipsen
Highlights of The Cervical Dystonia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Botulinum
- Anticholinergic Agents
- Dopaminergic Agents
- Others
- By Application:
- Hospital Pharmacy
- Retail Pharmacies
- Online Pharmacy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cervical Dystonia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cervical dystonia is a disorder of the neck muscles that causes abnormal muscle contractions. Treatment typically includes medication and/or physical therapy.
Some of the major companies in the cervical dystonia treatment market are Merz Pharma, US WorldMeds, Allergan, Ipsen.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cervical Dystonia Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cervical Dystonia Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cervical Dystonia Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cervical Dystonia Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cervical Dystonia Treatment Market Size & Forecast, 2018-2028
4.5.1 Cervical Dystonia Treatment Market Size and Y-o-Y Growth
4.5.2 Cervical Dystonia Treatment Market Absolute $ Opportunity
Chapter 5 Global Cervical Dystonia Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cervical Dystonia Treatment Market Size Forecast by Type
5.2.1 Botulinum
5.2.2 Anticholinergic Agents
5.2.3 Dopaminergic Agents
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cervical Dystonia Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cervical Dystonia Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacy
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cervical Dystonia Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cervical Dystonia Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cervical Dystonia Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Cervical Dystonia Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cervical Dystonia Treatment Market Size Forecast by Type
9.6.1 Botulinum
9.6.2 Anticholinergic Agents
9.6.3 Dopaminergic Agents
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cervical Dystonia Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacy
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cervical Dystonia Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Cervical Dystonia Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cervical Dystonia Treatment Market Size Forecast by Type
10.6.1 Botulinum
10.6.2 Anticholinergic Agents
10.6.3 Dopaminergic Agents
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cervical Dystonia Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacy
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cervical Dystonia Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cervical Dystonia Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cervical Dystonia Treatment Market Size Forecast by Type
11.6.1 Botulinum
11.6.2 Anticholinergic Agents
11.6.3 Dopaminergic Agents
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cervical Dystonia Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacy
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cervical Dystonia Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Cervical Dystonia Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cervical Dystonia Treatment Market Size Forecast by Type
12.6.1 Botulinum
12.6.2 Anticholinergic Agents
12.6.3 Dopaminergic Agents
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cervical Dystonia Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacy
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cervical Dystonia Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cervical Dystonia Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cervical Dystonia Treatment Market Size Forecast by Type
13.6.1 Botulinum
13.6.2 Anticholinergic Agents
13.6.3 Dopaminergic Agents
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cervical Dystonia Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacy
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cervical Dystonia Treatment Market: Competitive Dashboard
14.2 Global Cervical Dystonia Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merz Pharma
14.3.2 US WorldMeds
14.3.3 Allergan
14.3.4 Ipsen
